Profil
Michel Cimon worked as VP-Medical Affairs & Director-Medical Affairs at Merck KGaA from 2007 to 2011.
Prior to that, he was Director-Medical & Professional Affairs at GlaxoSmithKline, Inc. from 1996 to 2006.
He also worked as a Director at 4 Touchdowns Capital, Inc. Mr. Cimon's education includes an undergraduate degree from McGill University and an undergraduate degree from the University of Sherbrooke.
He also holds a graduate degree from the University of California.
Anciens postes connus de Michel Cimon
| Sociétés | Poste | Fin |
|---|---|---|
| KLOX TECHNOLOGIES INC | Directeur Technique/Scientifique/R&D | 01/02/2018 |
| MERCK KGAA | Directeur Technique/Scientifique/R&D | 01/12/2011 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Directeur Technique/Scientifique/R&D | 01/03/2006 |
4 Touchdowns Capital, Inc.
 4 Touchdowns Capital, Inc. Financial ConglomeratesFinance 4 Touchdowns Capital, Inc. provides investment services. Its principal business is to identify, evaluate and if warranted, acquire an interest in a business or assets. The company was founded on Febuary26, 2015 is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | - |
Formation de Michel Cimon
| McGill University | Undergraduate Degree |
| University of Sherbrooke | Undergraduate Degree |
| University of California | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Entreprise privées | 3 |
|---|---|
KLOX Technologies, Inc.
 KLOX Technologies, Inc. Medical SpecialtiesHealth Technology KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada. | Health Technology |
4 Touchdowns Capital, Inc.
4 Touchdowns Capital, Inc. Financial ConglomeratesFinance 4 Touchdowns Capital, Inc. provides investment services. Its principal business is to identify, evaluate and if warranted, acquire an interest in a business or assets. The company was founded on Febuary26, 2015 is headquartered in Vancouver, Canada. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
